Key facts
- It has raised $60K; the latest was Seed Round ($30K) in Nov 2025.
- Notable investors include Health Wildcatters.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for HarmonIQ Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for HarmonIQ Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HarmonIQ Biosciences
Developer of a hormone health technology company designed to deliver real-time hormone monitoring services. The company offers a continuous hormone monitoring device that combines biotechnology with aptamer-based sensing to deliver precise, real-time hormonal data, enabling customers to gain continuous insights into their endocrine health.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2025
- Website
- harmoniqbio.com/
- Ownership
- Privately Held (backing)
HarmonIQ Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HarmonIQ Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HarmonIQ Biosciences in its N-PORT filings yet. We sweep new filings monthly.